AI in Medicine News ・ 🩻 Diagnosis and imaging

Tempus Receives FDA Clearance for its AI Product Intended to Dete

The National Law Review 🔗 Share link 10/17 04:41 UTC 🔗 Share link AI Skin Cancer Models Burn Four Times More Energy for No Extra Accuracy — bioengineer.org · 10/18 08:11 UTC

The ECG-PH clearance adds pulmonary hypertension to Tempus' FDA-cleared AI products. Its existing cleared products cover atrial fibrillation and low ejection fraction.

Read the original (The National Law Review 🔗 Share link 10/17 04:41 UTC 🔗 Share link AI Skin Cancer Models Burn Four Times More Energy for No Extra Accuracy — bioengineer.org)

See it in the digest → ・ See this issue →